As clinical development programmes grow in scale and complexity, sponsors need confidence that safety and efficacy reviews are supported by accurate data, rigorous quality control, and independent statistical expertise.
In this case study, learn how Phastar supported a global HIV development programme involving multiple studies, repeated IDMC reviews, planned interim analyses, and urgent safety assessments.
By combining expert statistical programming, independent oversight, and proactive data quality review, our team helped ensure reliable decision-making throughout the programme.
Download the full case study to discover how Phastar helps sponsors strengthen clinical oversight and support successful global regulatory submissions.